双胎特异性与单胎生长参考在双绒毛膜双胎胎儿生长受限诊断中的比较
本研究为回顾性队列研究,纳入2004至2019年间单中心≥32周分娩的双绒毛膜双胎1460例,比较NICHD双胎特异性与Hadlock单胎生长参考诊断胎儿生长受限(EFW<10百分位)与不良新生儿结局的关联。结果显示两种参考均诊断FGR者不良结局风险显著升高,而仅Hadlock诊断FGR者与无FGR者结局无差异,提示双胎特异性参考更优。
要点
- NICHD双胎特异性参考比Hadlock单胎参考更能识别与不良新生儿结局相关的FGR。
- 仅Hadlock诊断FGR的双胎,其新生儿并发症风险与无FGR者无显著差异。
- 使用Hadlock单胎参考会使双胎FGR诊断数量增加一倍以上,可能带来过度干预。
核心结论
- NICHD双胎特异性生长参考能更好地识别双绒毛膜双胎中与不良新生儿结局相关的胎儿生长受限。
- Hadlock单胎生长参考会大幅增加双胎FGR诊断,但额外诊断者新生儿并发症风险低。
研究设计与样本
- 回顾性队列研究,纳入2004至2019年单中心≥32周分娩的双绒毛膜双胎,共1460例双胎婴儿。
- 利用分娩前最后一次生长超声,按Hadlock和NICHD参考将双胎分为三组:两者均FGR、仅Hadlock FGR、两者均无FGR,FGR定义为EFW<10百分位。
- 采用多变量广义线性混合模型进行组间两两比较,并纳入随机效应成分以考虑双胎配对相关性。
主要发现
- 8.1%(118例)双胎婴儿被两种参考均诊断为FGR,8.8%(129例)仅被Hadlock诊断,83.1%(1213例)两种参考均未诊断FGR。
- 仅Hadlock诊断FGR者与两种参考均无FGR者相比,复合新生儿病率无差异。
关键数值与推荐
- 胎儿生长受限定义为估计胎儿体重(EFW)<10百分位。
- Hadlock单胎生长参考与NICHD双胎特异性生长参考为比较的两种标准。
临床怎么用
- 在双绒毛膜双胎中,建议采用NICHD双胎特异性生长参考评估胎儿生长受限,以更准确识别高危儿。
- 避免仅凭Hadlock单胎参考诊断FGR,以减少不必要的母亲焦虑、产前监测及可能的医源性早产。
局限性
- 本研究为单中心回顾性队列研究,结果外推需谨慎。
- 仅纳入≥32周分娩且具备连续生长超声及新生儿结局数据的双绒毛膜双胎,可能存在选择偏倚。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fetal growth restriction is associated with an increased risk for adverse neonatal outcomes. The Hadlock singleton growth reference is widely used to determine the estimated fetal weight percentile for both twin and singleton gestations. The Eunice Kennedy Shriver National Institute of Child Health and Human Development's twin-specific growth reference accounts for the different growth trajectory that twins follow during gestation. There is a lack of research comparing these different growth references in their ability to identify fetal growth restriction that is associated with adverse neonatal outcomes in dichorionic twin gestations. OBJECTIVE: This study aimed to compare a twin-specific growth reference (the Eunice Kennedy Shriver National Institute of Child Health and Human Development's twin-specific growth reference) and a singleton growth reference (Hadlock) in their ability to identify fetal growth restriction associated with adverse neonatal outcomes in dichorionic twin gestations. STUDY DESIGN: This was a retrospective cohort study of dichorionic twin gestations at ≥32 weeks' gestation delivered at a single institution between 2004 and 2019 with the serial growth ultrasounds and neonatal outcomes data available for analysis. Using their last growth ultrasound before delivery, twins were classified into the following 3 categories: fetal growth restriction according to both the Hadlock and Eunice Kennedy Shriver National Institute of Child Health and Human Development references, fetal growth restriction according to the Hadlock reference only, and no fetal growth restriction according to either reference, with fetal growth restriction defined as an estimated fetal weight of <10th percentile for gestational age. Multivariable generalized linear mixed models were used to assess the adverse neonatal outcomes via pair-wise comparisons between the groups, with a random-effects component to account for twin-pair correlations. RESULTS: A total of 1460 dichorionic twin infants were included with 8.1% (n=118) of cases classified as fetal growth restricted by both the Eunice Kennedy Shriver National Institute of Child Health and Human Development and Hadlock references, 8.8% (n=129) of cases classified as fetal growth restricted by the Hadlock reference only, and 83.1% (n=1213) of cases classified as no fetal growth restriction by either reference. Compared with twins with no fetal growth restriction by either reference, twins with fetal growth restriction by both references were more likely to experience mild (adjusted odds ratio, 2.38; confidence interval, 1.38-4.13) or severe (adjusted odds ratio, 2.82; confidence interval, 1.16-6.88) composite neonatal morbidity. Compared with twins with fetal growth restriction according to the Hadlock reference only, twins with fetal growth restriction according to both references were more likely to experience mild (adjusted odds ratio, 2.03; confidence interval, 1.00-4.14) but not severe (adjusted odds ratio, 3.70; confidence interval, 0.72-18.90) composite neonatal morbidity. Composite neonatal morbidity was not different between twins with fetal growth restriction according to the Hadlock reference only and those with no fetal growth restriction by either growth reference. CONCLUSION: The Eunice Kennedy Shriver National Institute of Child Health and Human Development's twin-specific growth reference better identifies the risk for adverse neonatal outcomes in dichorionic twin gestations diagnosed with fetal growth restriction. The use of the Hadlock singleton growth reference more than doubles the number of dichorionic twins identified with fetal growth restriction who seem to be at a low-risk for neonatal morbidity, leading to unnecessary maternal anxiety, increased antenatal testing, and possibly iatrogenic preterm delivery.
引用
- Shea SK, Likins BJ, Boan AD, et al. Dichorionic twin-specific vs singleton growth references for diagnosis of fetal growth restriction. Am J Obstet Gynecol. 2021. PMID: 33771495. doi:10.1016/j.ajog.2021.03.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。